MaxCyte Debuts New State-of-the-Art Headquarters in Maryland’s I-270 Biotech Corridor - read this article along with other careers information, tips and advice on BioSpace
MaxCyte Debuts New State-of-the-Art Headquarters in Maryland s I-270 Biotech Corridor · BioBuzz biobuzz.io - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biobuzz.io Daily Mail and Mail on Sunday newspapers.
Expanded facilities illustrate MaxCyte’s commitment to Montgomery County and the state of Maryland, building the life sciences community, and propelling.
Expanded facilities illustrate MaxCyte’s commitment to Montgomery County and the state of Maryland, building the life sciences community, and propelling local
07.09.2022 - ROCKVILLE, Md., Sept. 07, 2022 (GLOBE NEWSWIRE) - MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as .